Clinical trial · Observational
Visualization of the Papilla Through Use of the NuView Device in Patients With FAP
NCT05657145CI-TRIAL-00101297NuViewcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this observational study is to test the NuView device in participants with familial adenomatous polyposis (FAP). The main question it aims to answer is: * can the papilla be visualized using a forward-facing endoscope outfitted with the NuView device. Participants will undergo standard of care esophagogastroduodenoscopy with an additional endoscopic exam using NuView device, for which participant have given prior consent.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Familial Adenomatous Polyposis | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Familiar Adenomatous Polyposis
- description
- All patient in this group will have the NuView device used to assist in the visualization of the papilla.
Primary outcomes (1)
- measure
- Visualization of papilla
- timeFrame
- 1 day
- description
- Successful visualization of the papilla with a standard gastroscope equipped with the NuView platform.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Male or female, 18 to 70 years of age. * Able to provide written informed consent. * Have FAP Exclusion Criteria: * Females who are pregnant. As part of routine pre-operative care, all females of childbearing potential will undergo either urine or blood pregnancy testing. * Cancer positive subjects or any patients currently undergoing any treatment or therapy to treat, cure, or mitigate cancer. * Patients who do not meet inclusion criteria * Patients who are unable or unwilling to provide informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.